Monday, 2 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Product Launch

Shelter Pharma Product Launch

Shelter Pharma launched FOLIMAN Folic Acid Tablets in international markets on May 11, 2026. This expansion into nutraceuticals aims to strengthen its global healthcare segment presence.

Source

BSE filing, BSE: 543963. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Shelter Pharma Ltd: key numbers

Share price
₹42.52
Market cap
₹73.57 Cr
Revenue (annual)
₹73.13 Cr
Net profit (annual)
₹9.03 Cr
P/E (TTM)
8.2×Sector 45.9×
Promoter holding
46.11%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Shelter Pharma Ltd

All →
19:45 IST BSE
New Order Win

Shelter Pharma Bags ₹3.47 Cr Order from Taha Drugs & Chemicals Co. Ltd.; First Vet Veterinary Medicines...

Shelter Pharma received export orders worth Rs. 3.47 Crore from three overseas buyers. Execution follows mutually agreed purchase-order schedules, in the normal course of business.

Value
₹3.47 Cr
From
Taha Drugs & Chemicals Co. Ltd.; First Vet Veterinary Medicines Trading L.L.C; Genet International
Execution
As per mutually agreed purchase order schedules

Other product launch announcements

All →